Rakuten Investment Management Inc. Purchases Shares of 38,371 Cardinal Health, Inc. $CAH

Posted by Stanley Muller on Aug 30th, 2026

Rakuten Investment Management Inc. acquired a new position in Cardinal Health, Inc. (NYSE:CAH – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 38,371 shares of the company’s stock, valued at approximately $9,064,000.

A number of other large investors have also recently bought and sold shares of the company. University of Texas Texas AM Investment Management Co. purchased a new position in Cardinal Health during the 4th quarter worth approximately $26,000. Bank of Jackson Hole Trust purchased a new stake in shares of Cardinal Health in the 4th quarter valued at $27,000. Jones Financial Companies Lllp boosted its holdings in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the last quarter. Palladiem LLC acquired a new stake in shares of Cardinal Health in the fourth quarter worth $28,000. Finally, Indiana Trust & Investment Management Co acquired a new stake in shares of Cardinal Health in the first quarter worth $29,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Insider Transactions at Cardinal Health

In other Cardinal Health news, CEO Jason M. Hollar sold 80,000 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $235.74, for a total transaction of $18,859,200.00. Following the completion of the transaction, the chief executive officer owned 235,132 shares of the company’s stock, valued at $55,430,017.68. This represents a 25.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Deborah Weitzman sold 7,354 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total value of $1,731,499.30. Following the completion of the transaction, the chief executive officer owned 77,901 shares in the company, valued at approximately $18,341,790.45. This trade represents a 8.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 210,271 shares of company stock worth $49,626,657 in the last three months. 0.12% of the stock is owned by corporate insiders.

Cardinal Health Stock Performance

Cardinal Health stock opened at $234.72 on Friday. The company’s fifty day moving average price is $233.10 and its 200 day moving average price is $218.42. Cardinal Health, Inc. has a 1 year low of $145.87 and a 1 year high of $258.30. The stock has a market capitalization of $54.59 billion, a P/E ratio of 32.46, a P/E/G ratio of 1.41 and a beta of 0.49.

Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. The company had revenue of $63.67 billion during the quarter, compared to analysts’ expectations of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the prior year, the business posted $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 12.55 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be paid a $0.5158 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is currently 28.49%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on CAH. Barclays boosted their target price on shares of Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, August 13th. Zacks Research downgraded Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Royal Bank Of Canada initiated coverage on Cardinal Health in a research note on Wednesday, August 19th. They set an “outperform” rating and a $276.00 price objective for the company. Leerink Partners set a $292.00 price objective on Cardinal Health in a report on Tuesday, August 11th. Finally, Mizuho upped their target price on Cardinal Health from $240.00 to $250.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 12th. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $266.56.

View Our Latest Stock Report on Cardinal Health

About Cardinal Health

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.